Diabetes. Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetes with peripheral neuropathy or a score of more than one using the NSS criteria Patient's willingness and written informed consent to participate in the study Neuropathic pain (score of one or more) according to the visual pain scale No history of disease or condition that affects neuropathy (stroke, multiple sclerosis, gout, Parkinson's, spinal cord injury, Guillain-Barré, rheumatic disease, thrombosis and vascular disorder) based on medical records and patient report Consciousness and ability to speak and communicate to report the severity of clinical symptoms during examination and examination Age under 60 years No cardiac arrhythmias according to the doctor's examination and confirmation No history of addiction to narcotics or strong painkillers according to the patient's statement No complete sensory impairment in the distal lower extremities and the presence of wounds and lesions at the site of heat therapy No The presence of fractures and traumatic injuries leading to sensory and motor impairments in the lower limbs
Exclusion criteria
Exclusion criteria: Unwillingness to continue cooperation during the study The occurrence of any disorder or special condition during the study that prevents the use of heat therapy or progressive muscle relaxation technique. The necessity of using any unforeseen pharmacological and non-pharmacological intervening factors affecting pain, fatigue, and quality of life during the study The occurrence of situational crises affecting the quality of life, such as divorce, death of relatives, bankruptcy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropathic Pain. Timepoint: Pre-intervention, Week 4, Week 6. Method of measurement: Visual Analogue Scale (VAS).;Fatigue. Timepoint: Pre-intervention, Week 4, Week 6. Method of measurement: Functional Assessment of Chronic Illness Treatment-Fatigue Scale (FACIT-F).;Quality of Life. Timepoint: Pre-intervention, Week 4, Week 6. Method of measurement: Diabetic Quality of Life Questionnaire (DQOL). | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptoms of diabetic neuropathy. Timepoint: Pre-intervention, week 4, week 6. Method of measurement: Diabetic Neuropathy Symptom Score (NSS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Gonabad University of Medical Sciences